Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Harvard Bioscience Community
NasdaqGM:HBIO Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
Harvard Bioscience
Popular
Undervalued
Overvalued
Community Investing Ideas
Harvard Bioscience
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Expanding SoHo, BTX, And Mesh MEA Will Open New Markets
Key Takeaways Expansion of SoHo platform and BTX systems could drive revenue growth in industrial and academic markets through broader applications and bioproduction processes. Cost-reduction and debt refinancing strategies are expected to enhance earnings and financial stability despite higher rates, improving the company's net margins and liquidity.
View narrative
US$3.00
FV
83.3% undervalued
intrinsic discount
0.78%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
HBIO
HBIO
Harvard Bioscience
Your Fair Value
US$
Current Price
US$0.50
92.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-58m
122m
2015
2018
2021
2024
2025
2027
2030
Revenue US$104.6m
Earnings US$12.9m
Advanced
Set Fair Value